Ley Steven V, Tackett Miles N, Maddess Matthew L, Anderson James C, Brennan Paul E, Cappi Michael W, Heer Jag P, Helgen Céline, Kori Masakuni, Kouklovsky Cyrille, Marsden Stephen P, Norman Joanne, Osborn David P, Palomero María A, Pavey John B J, Pinel Catherine, Robinson Lesley A, Schnaubelt Jürgen, Scott James S, Spilling Christopher D, Watanabe Hidenori, Wesson Kieron E, Willis Michael C
Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.
Chemistry. 2009;15(12):2874-914. doi: 10.1002/chem.200801656.
For over 30 years, rapamycin has generated a sustained and intense interest from the scientific community as a result of its exceptional pharmacological properties and challenging structural features. In addition to its well known therapeutic value as a potent immunosuppressive agent, rapamycin and its derivatives have recently gained prominence for the treatment of a wide variety of other human malignancies. Herein we disclose full details of our extensive investigation into the synthesis of rapamycin that culminated in a new and convergent preparation featuring a macro-etherification/catechol-templating strategy for construction of the macrocyclic core of this natural product.
30多年来,雷帕霉素因其卓越的药理特性和具有挑战性的结构特征,一直引起科学界持续而浓厚的兴趣。除了作为一种有效的免疫抑制剂具有众所周知的治疗价值外,雷帕霉素及其衍生物最近在治疗多种其他人类恶性肿瘤方面也备受关注。在此,我们披露了我们对雷帕霉素合成进行广泛研究的全部细节,该研究最终形成了一种新的汇聚式制备方法,其采用大环醚化/邻苯二酚模板策略构建这种天然产物的大环核心。